Back to results

University of Washington

Oncofetal Proteins Drive Aggressive Disease in Basal Pancreatic Cancer

Abstract

dc:description.abstract

Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer arising from the exocrine pancreas. Unlike most other solid tumors, incidence and mortality from PDAC continues to rise in the United States. PDAC is typically diagnosed after it has metastasized to other organs, and the only treatment option for advanced disease is combination chemotherapy. Targeted small molecule inhibitors and immunotherapies have encountered rapid resistance and are not yet clinically approved. Identifying disease subtypes and targeting therapies to these subtypes remains of crucial importance to improve outcomes.We have found that the chromatin-associated protein high mobility group AT-hook 2 (HMGA2) is differentially regulated in the most lethal subtypes of PDAC. In addition to predicting worse overall survival, high levels of HMGA2 in primary tumors also correlate with shorter time to disease recurrence and chemoresistance. In preclinical studies, HMGA2 expression is sufficient to drive aggressive disease in human and murine models of PDAC and leads to increased translation. This phenotype can be specifically targeted with inhibitors of protein synthesis. Finally, HMGA2 levels lead to altered cytokine secretion from tumor cells, fundamentally reshaping the tumor microenvironment and potentially defining key targets to rewire the profound immunosuppression seen in these tumors. Together, these studies define the oncofetal protein HMGA2 as a driver of aggressive disease in PDAC and elucidate the intracellular and extracellular mechanisms that lead to this lethal phenotype. We propose that levels of HMGA2 can be used clinically to define subsets of PDAC patients who will respond to targeted and immune modulating therapies.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Yamamoto, Naomi
Advisor dc:contributor.advisor
  • Kugel, Sita

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • none
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1773/55534
OAI identifier oai:identifier
oai:digital.lib.washington.edu:1773/55534

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Yamamoto, Naomi. Oncofetal Proteins Drive Aggressive Disease in Basal Pancreatic Cancer. 2026. https://hdl.handle.net/1773/55534